ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy in Patients With ST-segment Elevation Myocardial Infarction
Phase of Trial: Phase II/III
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms RAPID STEMI
- 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
- 07 Jul 2012 Planned end date changed from 1 Mar 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 18 Oct 2011 New trial record